COVID-19 cases are on the rise again across the United States, with the biggest increases in parts of the South, Southeast, and West Coast.

Moderna’s COVID-19 vaccine has received full FDA approval for use in children at higher risk for severe illness.

The multicomponent mRNA-1083 vaccine elicited noninferior immune responses in adult patients when compared with coadministered influenza and COVID-19 vaccines.

The prevalence of long COVID-typical symptom clusters was relatively high among a cohort of adults 2 years after initial COVID-19 infection.

Nurse practitioners form the key to providing culturally competent care, which improves outcomes for Asian American patients.

Kraft Heinz Foods is recalling some 370,000 pounds of fully cooked turkey bacon products that may be contaminated with listeria.

Several medical organizations are suing the HHS and Secretary Robert F. Kennedy Jr based on recent actions resulting in significant changes in vaccine policy in the US.

The Trump administration's recent travel and visa restrictions have left some hospitals in the United States without essential staff.

The US FDA has published more than 200 complete response letters sent as replies to drug and biological product applications.

The FDA has approved Tyzavan, a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various bacterial infections.

Children with hematologic malignancies continue to exhibit increased IPD risk despite an overall decline in pediatric IPD after the introduction of the PCV13 vaccine.

Incomplete immune recovery despite sustained virologic suppression in patients with HIV was associated with increased risk for incident cancer.